ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 659616 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 659616; 2) Community: the network communities that were significantly associated with the response to NSC 659616; 3) Molecule: the relationships between components within communities and NSC 659616; 4) MDR: the compounds that were significantly associated with the NSC 659616.

NSC Compound Enrichment Correlation
NSC 639516 Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(3,4- dimethoxyphenyl)methylene]-, hydrochloride 0.0342636096654276 0.39468966
NSC 639518 Cyclopentanone, 2-[[4-(benzoyloxy)-3-methoxyphenyl] methylene]-5-[(dimethylamino)methyl]-, hydrochloride 0.0342636096654276 0.4330979
NSC 643841 Null 0.0342636096654276 0.13743464
NSC 647395 Null 0.0342636096654276 0.29223676
NSC 654378 Null 0.0342636096654276 0.21895379
NSC 654509 Pirarubicin HCl 0.0342636096654276 0.39443376
NSC 658828 Null 0.0342636096654276 0.23532997
NSC 659778 Null 0.0385203205529756 0.4049299
NSC 661748 [6,6'-Bibenzo[6,7]cyclohepta[1,2,3-cd]benzofuran]-4,4',8,8', 10,10'-hexol, 1,1',6,6',7,7',11b,11'b-octahydro-1,1',7,7'- tetrakis(4-hydroxyphenyl)-, [1.alpha.,6.beta.(1'R*,6'S*,7'R*),7.alpha]- 0.0385203205529756 -0.21439737
NSC 662253 Null 0.0385203205529756 0.21338277
Total:115  Current:87    [First] [Prev] [Next] [Last]